Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 701–800 of 1,000
Wellness Interventions in Patients Living with Chronic Medical Conditions
Steiner, A. J., Aguilar-Hernandez, L., Pizano, D. R., Dascal, J., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.014 · Cited by 2
Allergic, Infectious, and Immunological Processes
Riaz, O., Orimaye, S. O., Al-Khateeb, T., Sodeke, P. O., Awujoola, A. O., & Goodkin, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.012 · Cited by 2
IsHak, W. W., Mann, A., Manoukian, V., Pakhdikian, S., Chaudhry, M., Liu, A., & Bart, R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.001 · Cited by 2
Perera, D. M., & Moe, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.005 · Cited by 2
The Role of Leisure, Recreation, and Play in Health and Well-Being
Payne, L. L., & An, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.048 · Cited by 2
Wellness Interventions in the Workplace
Chernoff, R. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.020 · Cited by 3
IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.052 · Cited by 2
Postbiotics and their therapeutic effects: a review
Köktürk, S. N., & Yardımcı, H. (2023) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000383 · Cited by 2
“According to the report of WHO and FAO, probiotics have side effects such as systemic infection, harmful metabolic activities, over-reacted immune system in an individual who is susceptible , gene transfer and mild gastrointestinal symptoms [5].”
The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review
Tang, C., Qian, Y., Jia, S., Zhang, J., Zhang, Y., Ren, Y., Yong, H., Xu, J., Kan, J., & Liu, J. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10753-6 · Cited by 2
“In the context of high-fat diet, high levels of free fatty acids increase the number and self-renewal capacity of leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5) + intestinal stem cells, and consequently cause intestinal tumorigenicity [359, 364].”
Limosilactobacillus reuteri in Pediatric Oral Health: A Systematic Review
Carvalho, J. P. D. S., Grondin, R., Rompante, P., Rodrigues, C. F., Andrade, J. C., & Rajão, A. (2025) · Applied Sciences · doi:10.3390/app152111783 · Cited by 2
Reveles, K. R., Young, E. H., Zeidan, A. R., & Dong, Q. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00017-2 · Cited by 2
Castro-López, C., García-Galaz, A., Garcia, H. S., González-Córdova, A. F., Vallejo‐Córdoba, B., & Hernández‐Mendoza, A. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-01059-2 · Cited by 2
“, premature infants, patients with short bowel syndrome, patients with cardiac valve disease, or compromised immune system) may experience side effects, which are still poorly understood [4].”
BackgroundChong, S. Y., Raja‐Razali, R. B., Ismail, N. H., Ushidee-Radzi, M. A., Zahia-Azizan, N. A., Manickam, M., Norhisham, D. ‘., Ilham, Z., Reale, A., Nazzaro, S., et al. (2026) · Foods · doi:10.3390/foods15122079 · Cited by 2
“These microorganisms may be incorporated alone or in combination with starter cultures, contributing not only to probiotic functionality but also to improvements in flavor, texture, and nutritional quality [ 227– 277 ].”
Probiotic Yeasts and Bacteria: A Complementary Approach to Gut Health
Cicero, A. F. G., Bartoli, C., Lluís-Ganella, C., & Fabrizzi, P. (2026) · Microorganisms · doi:10.3390/microorganisms14081763 · Cited by 2
“This observation led to a research tradition that now includes thousands of clinical trials and has established a range of bacterial genera, mainly Lacticaseibacillus and Bifidobacterium , as safe and efficacious agents for supporting gut health across diverse clinical contexts [21,24].”
Nami, Y., Barghi, A., Sadeghi, M., Farhadi, T., Babaei, S., & Haghshenas, B. (2025) · Apmis · doi:10.1111/apm.70086 · Cited by 2
Nutritional Therapies for Irritable Bowel Syndrome: a Focus on Prebiotics and Probiotics
Zoll, B. E., & Ahuja, N. K. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00320-z · Cited by 2
Bohra, R., Bhardwaj, K., & Rajawat, N. K. (2026) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2026.100027 · Cited by 2
Shibata, Y., Asai, N., Hagihara, M., & Mikamo, H. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102794 · Cited by 2
A review of gut microbiota as a therapeutic approach for Parkinson’s disease
Ghosh, D., Ghosh, S., Sharma, M., & Datta, S. (2024) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_296_24 · Cited by 2
Recently Progressed Postbiotics as Nutraceuticals
Jeong, G. (2021) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2021.1.e33 · Cited by 2
Takahashi, J., & Rindfleisch, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00105-5 · Cited by 2
Киселева, М. А., Киселева, Т. Л., & Хлебников, Е. В. (2024) · Традиционная медицина · doi:10.54296/18186173_2024_3_17 · Cited by 2
Can use of probiotics drugs cause fungemia? – a literature review
Carneiro, S. D. S., de Freitas, H. F., & Guimarães, C. D. R. E. (2022) · Research Society and Development · doi:10.33448/rsd-v11i9.32030 · Cited by 2
“According to the US Food and Drug Administration (FDA) (2013) (Doron & Snydman, 2015), inpatients are considered a potential risk group for the development of fungemia with the use of probiotics, including also pregnant women, patients with disease structural heart disease and those with the…”
BackgroundMethodProbiotics for Infection Prevention in Critically Ill and Trauma Patients: A Concise Review
Vitko, H. A., Troxell, J. J., & Sherwood, P. R. (2023) · Journal of Trauma Nursing · doi:10.1097/jtn.0000000000000744 · Cited by 2
Wang, C., Xu, Z., Wang, P., Zhang, Q., & Xiang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1787393 · Cited by 2
“However, their live-microbial nature entails poor stability, susceptibility to environmental factors, and inconsistent ef fi cacy across numerous clinical trials (108 – 110).”
Li, C., Peng, H., Lu, F., Zhang, G., Xu, N., Chen, X., & Gao, X. (2025) · Medicine · doi:10.1097/md.0000000000045513 · Cited by 2
“[58,59] The gut-lung axis plays a synergistic role in maintaining immune and lung physiological function.”
Mitigating risk of bloodstream infection related to inpatient probiotic use
Polito, N. B., & Avery, L. M. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp180092 · Cited by 2
Regulatory Frameworks and Safety Considerations for Microbial Applications
Abraham, A., & Ifeanyi, S. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-98700-7_16 · Cited by 2
Santis, H. R. P., Molina, R. A. P., & Franco, L. F. L. (2020) · Revista de Investigaciones Veterinarias del Perú · doi:10.15381/rivep.v31i2.17935 · Cited by 2
Remodeling gut microbiota by Streptococcus thermophilus 19 attenuates inflammation in septic micePreprint
Han, F., Zhang, Y., Yang, X., Fang, Z., Han, S., Li, X., Cai, W., Xiao, D., Liu, J., Zhang, W., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/543967 · Cited by 2
Yeast and its derivatives in animal and fish nutrition
Hassan, F., Mehboob, M., Bilal, R. M., Siddique, F., & Alagawany, M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13510-1.00013-x · Cited by 2
Probióticos na DRC: esperando pela evidência
Campos, L. F. (2023) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-e005pt · Cited by 2
Probiotics in CKD: waiting for the evidence
Campos, L. F. (2023) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-e005en · Cited by 2
“WHO/ FAO recommend that new strains be evaluated for safety in human studies to assess side effects 7 .”
BackgroundZhao, X., Wei, X., Jiao, Q., Gou, Q., Zhang, Y., Peng, C., & Pan, Q. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274244 · Cited by 2
“Lactobacillus, as a common probiotic, has been reported to have multiple benefits [50].”
BackgroundDevelopment of Probiotics for Helicobacter pylori Infection Management
Mulay, V., Satav, D., Fernandez, A., Pisalwar, P., & Ahmed, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-1854-4_20 · Cited by 2
Coca, M. R., Pérez-Fernández, C., Abreu, A. C., Salmerón, A. M., Morales‐Navas, M., Ruiz‐Sobremazas, D., Colomina, M. T., Fernández, I., & Sánchez-Santed, F. (2025) · Food Frontiers · doi:10.1002/fft2.70165 · Cited by 2
Efficacy of Laurus nobilis L. for Tight Junction Protein Imbalance in Leaky Gut Syndrome
Shin, Y., Kim, J., Song, Y., Kim, G.-C., & Kong, H. (2024) · Nutrients · doi:10.3390/nu16091250 · Cited by 2
“In addition, if probiotics are taken while the inner wall of the intestine is not healthy, they penetrate between the intestines and act as a foreign substance, which can cause acute inflammation; therefore, patients with LGS need to consult a specialist before taking probiotics [16,17].”
BackgroundPlace des pré- et probiotiques dans la stratégie thérapeutique
Malbos, D. (2021) · Actualités Pharmaceutiques · doi:10.1016/j.actpha.2021.04.004 · Cited by 2
Probiotic Supplement Improves the Health Status and Lactation Performance in Dairy Animals
Ghazanfar, S., Riaz, A., Tahir, M. N., Maqbool, S., Ali, G. M., Tariq, F., & Arif, I. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.85779 · Cited by 2
“So, in order to alleviate the problems associated with the antibiotic use, a number of replacement have been proposed, and one of them is the effectiveness of probiotics [7].”
Perinatal Gut Dysbiosis Reduces Milk Oligosaccharides via LPS‐Mediated Gut–Mammary Signaling in Mice
Zhou, M., Wang, Y., Kang, Y., Walayat, B., Rui, B., Xue, Q., He, X., Yan, J., Liu, Y., & Li, M. (2025) · Food Frontiers · doi:10.1002/fft2.70171 · Cited by 2
Milani, T. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-19072018-100036 · Cited by 2
Safety evaluation of Bifidobacterium breve MCC1274 via oral toxicity tests in rats
Arai, S., Minami, J.-I., Muto, M., Iwabuchi, N., Yamauchi, K., Xiao, J., & Abe, F. (2018) · Toxicology Research and Application · doi:10.1177/2397847318807373 · Cited by 2
Lazarenko, L. M., Babenko, L. P., & Spivak, M. Y. (2019) · Mikrobiolohichnyi Zhurnal · doi:10.15407/microbiolj81.06.069 · Cited by 2
Nataraj, B. H., Ranveer, S. A., Jeevan, K., Nagpal, R., & Behare, P. V. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106927 · Cited by 2
Biodegradation of mycotoxins using postbiotics
Hiththatiyage, R., Wickramasinghe, M. A., Rathnayaka, I., Dias, C., Rambodagedara, S., Jayawardana, B. C., & Liyanage, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22188-0.00040-1 · Cited by 2
Smith, B., Smith, H., & Machini, M. (2024) · Cureus · doi:10.7759/cureus.65357 · Cited by 2
“Adverse side effects such as systemic infections, gene transfer, gastrointestinal side effects, and excessive immune stimulation have only been theorized to accompany the use of synbiotics based on the results from various case reports, clinical trials, and experimental models [28].”
BackgroundWidiatma, R. R., Listiawan, M. Y., Murtiastutik, D., Prakoeswa, C. R. S., Sawitri, S., Suryono, I. S., Astari, L., & Hidayati, A. N. (2020) · Berkala Ilmu Kesehatan Kulit dan Kelamin · doi:10.20473/bikk.v32.3.2020.214-220 · Cited by 2
Daily probiotics: benefits and reasonable application
Shulpekova, Y. O., & Rusyaev, V. Y. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-15-136-143 · Cited by 2
Kotolová, H. (2020) · Urologie pro praxi · doi:10.36290/uro.2020.025 · Cited by 2
“stupující chemoterapie nebo ozařování (21).”
Chernov, V. M., Chernova, O. A., & Trushin, M. V. (2023) · Archives of Razi Institute · doi:10.32592/ari.2024.79.1.28 · Cited by 2
Control of Allergy with Probiotics and Its Safety
Lee, Y., & Yoon, Y. (2020) · Journal of Dairy Science and Biotechnology · doi:10.22424/jdsb.2020.38.1.19 · Cited by 2
“또한 2002년 WHO와 FAO에서 발표한 프로바이오 틱스의 4가지 주요 부작용으로는 전신 감염, 유해 대사 작용, 민감한 개인의 면역 과도 반응 및 유전자 변형 등이 제시되었다[51].”
Probiotics and Infection Prevention
Perry, W. A., & Doron, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60980-5_22 · Cited by 2
Self-citationZhang, Y., He, Y., Sun, M., Ma, Y., Gao, Y., Feng, Y., Zhu, Y., Nan, B., Li, X., Liu, J., et al. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250815 · Cited by 2
Barba-Vidal, E., & Aliments, U. A. D. B. D. D. C. A. I. D. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
ExoBDNF Probiotic Supplementation Enhances Cognition in Subjective Cognitive Decline
Lin, C., Chen, L. M., Fang, W., Chang, C.-C., & Chang, H.-A. (2025) · Medicina · doi:10.3390/medicina62010091 · Cited by 2
“Safety data demonstrate that probiotics are generally well tolerated and do not result in a statistically significant increase in adverse events relative to placebo [49].”
Kim, Y. S., Park, S.-Y., Kang, S. J., Lee, M. W., Choi, Y., Kim, B. Y., Choi, M., Shin, C. M., Kim, Y. S., Kim, N., et al. (2026) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm25221 · Cited by 2
“144,145 However, safety data varies widely depending on the strains and formulations used, and most trials have methodological limitations, such as inadequate reporting of adverse events and insufficient follow-up to assess long-term risks.”
Hage, R. E. (2019) · Ghent University Academic Bibliography (Ghent University) · Cited by 2
Phương, H. T. A., Hải, P. V., Giang, L. T. K., Đức, L. M., Khương, N. Đ. T., & Hòa, N. X. (2024) · HUE UNIVERSITY JOURNAL OF SCIENCE ECONOMICS AND DEVELOPMENT · doi:10.26459/hueunijard.v133i3c.7611 · Cited by 2
Mekuria, S. A., Teshager, A. A., Atanaw, M. B., & Endeshaw, A. G. (2024) · Cogent Food & Agriculture · doi:10.1080/23311932.2023.2295078 · Cited by 2
“Feeds were analysed using standard (AOAc, 2005) procedures for dry matter (doron & snydman, 2015), which was determined by using a circulating hot-air oven (#925.09).”
InfluentialWiull, K. (2018) · NVA (Nasjonalt vitenarkiv) · Cited by 2
Pakdaman, M. N., Udani, J. K., Molina, J. P., & Shahani, M. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0199-0 · Cited by 2
Microbiome: A Novel Therapeutics in Cancer Management
Oniyangi, A. G., & Nazir, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00004-8 · Cited by 1
Ooi, S. L., & Pak, S. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.033 · Cited by 1
Management of COVID-19 and clinical nutrition
Peverini, M., & Barberini, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18703-2.00050-5 · Cited by 1
The Biopsychosocial Assessment
Somjee, L., & Esbitt, S. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.003 · Cited by 1
Emotional Intelligence and Its Role in Sustaining Fulfillment in Life
Sax, H. C., & Gewertz, B. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.038 · Cited by 1
Volle, D. C., & DeBonis, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.023 · Cited by 1
Melchert, T. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.004 · Cited by 1
Reproductive System: Pregnancy and Postpartum Wellness
Ogunyemi, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.011 · Cited by 1
Psychobiotics and fermented food interventions targeting the gut-brain axis in Alzheimer’s diseases
Mabrok, H. B., & Mohamed, D. A. (2026) · Discover Aging · doi:10.1007/s44518-026-00004-3 · Cited by 1
Forgiveness, Gratitude, and Spirituality
Idicula, S. A., Thrower, N., & Lomax, J. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.029 · Cited by 1
The application of fecal microbiota transplantation in Parkinson’s disease
Wang, B., Ma, D., Li, N., & Luo, T. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1713899 · Cited by 1
Family Relations, Friendships, and Love
Alsup, S., Weisbaum, E., Vogel, T., & Siegel, D. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.047 · Cited by 1
Wang, J., Wei, Y., Chen, D., Li, X., Zhang, H., Feng, S., Lu, S., Yang, J., Zeng, Q., He, X., et al. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70283 · Cited by 1
“Documented complications include systemic infections, deleterious metabolic activities, excessive immune activation in predisposed individuals, horizontal gene transfer, and gastrointestinal disturbances (Doron and Snydman 2015).”
Ruga, S., Matarese, E., Bava, R., Lombardi, C., Dimatteo, T., Miscio, L., Raponi, M., Giordano, A., Sansone, C., Liguori, G., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19081230 · Cited by 1
Spínello, P., do Nascimento, P., da Silveira, V. C., Staudt, T., Omidian, H., Tissiani, A. C., & Bertol, C. D. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878286133240418114629 · Cited by 1
Safety and Effectiveness of Probiotic Preparations: A Contemporary Review
Shorabaev, E., Sadanov, A. K., Baimakhanova, B. B., Ратникова, И. А., Xetayeva, G., Akhelova, S., & Turgumbayeva, A. (2026) · Diseases · doi:10.3390/diseases14090316 · Cited by 1
“Nevertheless, these findings should be interpreted with caution, as safety was not the primary endpoint in many clinical studies, and considerable variability exists in the methods used to identify, classify, and report adverse events, limiting the accuracy of risk estimation [23].”
InfluentialCappella, C., Redaelli, C., Balzarotti, M., Scarcia, P., Agrimi, G., & Bettiga, M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2673679 · Cited by 1
“55 S. boulardii exemplifies how a well-characterized, approved probiotic can function as a bridge strategy when guided by mechanistic understanding and indication-specific evidence.”
Stanley, C., Ogbonnaya, U. C., Ibezim, C. N. E., & Alex-Wele, M. A. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014300 · Cited by 1
Yoshinaga, S., Watanabe, M., Ito, H., Hatakeyama, S., Saitou, Y., Yamamura, R., Hashimoto, N., Nanmoku, T., Ohkusu, K., & Suzuki, H. (2026) · New Microbes and New Infections · doi:10.1016/j.nmni.2026.101821 · Cited by 1
“Adverse events associated with probiotic preparations are generally limited to mild gastrointestinal symptoms, and serious complications are rare [6].”
Liu, W., Lü, N., Zhou, X., Li, Y., Xie, Y., Zheng, L., Zhu, W., Xiao, Q., Yang, N., Zuo, K., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101085 · Cited by 1
Hygiene, J. O. P. M. A. (2022) · PubMed Central · doi:10.15167/2421-4248/jpmh2022.63.3s1 · Cited by 1
Ilboudo, C. M., & Bratcher, D. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00133-6 · Cited by 1
Characterization of Lactobacillus Isolates from Human Mouth and Feces as Probiotics
Ali, W. S., & Reza, A. T. A. (2020) · Cihan University-Erbil Scientific Journal · doi:10.24086/cuesj.v4n1y2020.pp7-12 · Cited by 1
“”[3] The US Food and Drug Administration stated that the probiotic is considered as generally recognized as safe.[4] Many studies showed that probiotics are used effectively to do many beneficial functions to the host[5-9] when they are taken in adequate quantity, and the recommended dosage of them is ranged usually b…”
BackgroundChapter 20: Prebiotics and Probiotics
Kale-Pradhan, P. B., & Wilhelm, S. M. (2017) · The American Pharmacists Association eBooks · doi:10.21019/9781582122656.ch20 · Cited by 1
Practical aspects of probiotics application: A Delphi study
Gorelov, A. V., Livzan, M. A., Zyryanov, S. K., Belmer, S. V., Zolnikova, O. Y., Михайлович, З. С., Usenko, D. V., & Dovgan, Y. V. (2024) · Terapevticheskii arkhiv · doi:10.26442/00403660.2024.12.203102 · Cited by 1
Probiotics effect in prevention and treatment of atopic dermatitis and eczema in children
Dima, V., Iancu, G., Bohîlțea, R. E., Toma, A. I., Avramescu-Calomfirescu, A., Varlas, V. N., & Daviţoiu, A. M. (2022) · Romanian Journal of Pharmaceutical Practice · doi:10.37897/rjphp.2022.2.4 · Cited by 1
Yoghurt (LAB) as preventive method against COVID-19
Bose, K. (2023) · Journal of Medical Clinical Case Reports · doi:10.47485/2767-5416.1031 · Cited by 1
Silva, D. R., Sakaguchi, O. A. S., da Silva, A. C. B., Sardi, J. D. C. O., de Carvalho, R. D. P., Roque, S. M., Borges, L. P. S., Lins, R. B. E., Campos, L. T., & Costa, E. M. M. D. B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98865 · Cited by 1
Food and mood: healthy eating for mental health with chronic kidney disease
Jackson, H. S. (2022) · Journal of Kidney Care · doi:10.12968/jokc.2022.7.4.172 · Cited by 1
Should Pediatric Infectious Diseases Physicians be Proponents of Probiotics?
Robinson, J. L. (2015) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2015/628630 · Cited by 1
“There are theoretical concerns that probiotics may increase oxygen demand in the gut mucosa, leading to ischemia in seriously ill patients, or may transfer resistance genes to other GI flora (29).”
Liu, S., Feng, S., Yuan, Z., Mei, Z., Yin, J., Chen, L., & Zhang, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1867014 · Cited by 1
Tran, H. M. (2020) · Chula Digiverse · doi:10.58837/chula.the.2020.473 · Cited by 1
Next Generation Probiotics Challenges: A Road to use as Live Bio-Therapeutics
and, H. R., Zaidi, A., & Rashid, H. (2026) · Current Microbiology · doi:10.1007/s00284-026-05044-4 · Cited by 1
“Since NGPs are defined as LBPs, i.e., drugs, an IND application is required before their research progresses in clinical areas because they are developed with the notion of either cure, prevention, mitigation, diagnosis or treatment of a disease [22].”
Le, Q. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1902756 · Cited by 1
“Probiotic administration, while generally safe for healthy individuals, may pose risks in immunocompromised individuals, those with central venous catheters, or patients with short bowel syndrome (Doron and Snydman, 2015).”
Probiotic–polyphenol synergy: Emerging insights for gut microbiome health and functional food design
Bhuiyan, M. N. I. (2026) · The Microbe · doi:10.1016/j.microb.2026.100765 · Cited by 1
Vishwakarma, M., Anitha, K., Ashique, S., & Mishra, N. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104697 · Cited by 1
Lazarenko, L. M., Bubnov, R. V., Babenko, L. P., Melnykova, O., & NIa, S. (2020) · ScienceRise Biological Science · doi:10.15587/2519-8025.2020.202216 · Cited by 1
Microbial vitamins as nutraceuticals and their role as health-promoting agents
Ahmad, M. F., Ahmad, F. A., Ashraf, S. A., Alsayegh, A. A., Tabassum, F., Bantun, F., Elbandy, M., Shama, E., Uddin, S., & Khanam, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15528-4.00010-6 · Cited by 1
The role of probiotics in the prevention of disease
Joshi, M. R. (2016) · Gastrointestinal Nursing · doi:10.12968/gasn.2016.14.4.21 · Cited by 1
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.